Phex mutation causes overexpression of FGF23 in teeth

Archives of Oral Biology

Volumn 53, Issue 2, 2008, Pages 99-104

  Onishi, T ^a   Umemura, S ^a   Shintani, S ^a   Ooshima, T ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Fibroblast growth factor 23; Hyp mouse; Tooth development; X linked hypophosphatemic vitamin D resistant rickets

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; PHEX PROTEIN, MOUSE; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BLOOD; BONE DENSITY; BONE MINERALIZATION; C57BL MOUSE; GENE EXPRESSION; GENETICS; MALE; METABOLISM; MOUSE; MUTATION; TOOTH; TOOTH DISEASE;

ANIMALS; BONE DENSITY; CALCIFICATION, PHYSIOLOGIC; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; MALE; MICE; MICE, INBRED C57BL; MUTATION; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; TOOTH; TOOTH DISEASES;

MUS;

EID: 37349128887     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2007.08.009     Document Type: Article

References (26)

1. Yamashita T., Yoshioka M., and Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun 277 (2000) 494-498
2. ADHR Consortium. Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26 (2000) 345-348
3. White K.E., Carn G., Lorenz-Depiereux B., Benet-Pages A., Strom T.M., and Econs M.J. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60 (2001) 2079-2086
4. Shimada T., Muto T., Urakawa I., Yoneya T., Yamazaki Y., Okawa K., et al. Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143 (2002) 3179-3182
5. Yamazaki Y., Okazaki R., Shibata M., Hasegawa Y., Satoh K., Tajima T., et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87 (2002) 4957-4960
6. Jonsson K.B., Zahradnik R., Larsson T., White K.E., Sugimoto T., Imanishi Y., et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348 (2003) 1656-1663
7. Abe K., Ooshima T., Tong S.M.L., Yasufuku Y., and Sobue S. Structural deformities of deciduous teeth in patients with hypophosphatemic vitamin D-resistant rickets. Oral Surg Oral Med Oral Pathol 65 (1988) 191-198
8. Goodman J.R., Gelbier M.J., Bennett J.H., and Winter G.B. Dental problems associated with hypophosphataemic vitamin D resistant rickets. Int J Paediatr Dent 8 (1988) 19-28
9. The HYP Consortium. A gene (Pex) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11 (1995) 130-136
10. Dixon P.H., Christie P.T., Wooding C., Trump D., Grieff M., Holm I., et al. Mutational analysis of PHEX gene in X-linked hypophosphatemia. J Clin Endocrinol Metab 83 (1998) 3615-3623
11. Eicher E.M., Southard J.L., Scriver C.R., and Glorieux F.H. Hypophosphatemia. Mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73 (1976) 4667-4671
12. Tenenhouse H.S., Scriver C.R., McInnes R.R., and Glorieux F.H. Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: evidence for a defect in the brush border membrane. Kidney Int 14 (1978) 236-244
13. Beck L., Soumounou Y., Martel J., Krishnamurthy G., Gauthier C., Goodyer C.G., et al. Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 99 (1997) 1200-1209
14. Strom T.M., Francis F., Lorenz B., Boddrich A., Econs M.J., Lehrach H., et al. Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet 6 (1997) 165-171
15. Liu S., Zhou J., Tang W., Jiang X., Rowe D.W., and Quarles L.D. Pathogenic role of FGF23 in Hyp mice. Am J Physiol Endocrinol Metab 291 (2006) 38-49
16. Yoshiko Y., Wang H., Minamizaki T., Ijuin C., Yamamoto R., Suemune S., et al. Mineralized tissue cells are a principal source of FGF23. Bone 40 (2007) 1565-1573
17. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98 (2001) 5945-5946
18. Weber T.J., Liu S., Indridason O.S., and Quarles L.D. Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18 (2003) 1227-1234
19. Liu S., Guo R., Simpson L.G., Xiao Z.S., Burnham C.E., and Quarles L.D. Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278 (2003) 37419-37426
20. Yamada M., Bringas Jr. P., Grodin M., MacDougall M., Cummings E., Grimmett J., et al. Chemically-defined organ culture of embryonic mouse tooth organs: morphogenesis, dentinogenesis and amelogenesis. J Biol Buccale 8 (1980) 127-139
21. Ruchon A.F., Marcinkiewicz M., Siegfried G., Tenenhouse H.S., DesGroseillers L., Crine P., et al. Pex mRNA is localized in developing mouse osteoblasts and odontoblasts. J Histochem Cytochem 46 (1998) 459-468
22. Turner A.J., Brown C.D., Carson J.A., and Barnes K. The neprilysin family in health and disease. Adv Exp Med Biol 477 (2000) 229-240
23. Shimada T., Yamazaki Y., Takahashi M., Hasegawa H., Urakawa I., Oshima T., et al. Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 289 (2005) F1088-F1095
24. Perwad F., Azam N., Zhang M.Y., Yamashita T., Tenenhouse H.S., and Portale A.A. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146 (2005) 5358-5364
25. Kolek O.I., Hines E.R., Jones M.D., LeSueur L.K., Lipko M.A., Kiela P.R., et al. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol 289 (2005) G1036-G1042
26. Liu S., Tang W., Zhou J., Stubbs J.R., Luo Q., Pi M., et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17 (2006) 1305-1315